Invention Grant
US07838675B2 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
有权
嘧啶磺酰胺衍生物作为趋化因子受体调节剂
- Patent Title: Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent Title (中): 嘧啶磺酰胺衍生物作为趋化因子受体调节剂
-
Application No.: US11574340Application Date: 2005-08-23
-
Publication No.: US07838675B2Publication Date: 2010-11-23
- Inventor: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Jeffrey Paul Stonehouse
- Applicant: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Jeffrey Paul Stonehouse
- Applicant Address: SE Södertälje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Södertälje
- Agency: Fish & Richardson P.C.
- Priority: GB0419235.7 20040828; GB0502544.0 20050208
- International Application: PCT/GB2005/003257 WO 20050823
- International Announcement: WO2006/024823 WO 20060309
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/506 ; A61P19/02 ; A61P11/06
Abstract:
A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
Public/Granted literature
- US20080096860A1 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators Public/Granted day:2008-04-24
Information query
